Halozyme Therapeutics, Inc.

SHELTON CAPITAL MANAGEMENT HALO

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/17/2026

Shares

3,958

Value ($000)

266

Weight

0.0%

2020 Q4 - 2025 Q4 (21 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/17/2026	266	0.0%	3,958	12/31/2025
2025 Q3	11/14/2025	331	0.0%	4,513	9/30/2025
2025 Q2	8/13/2025	235	0.0%	4,513	6/30/2025
2025 Q1	5/15/2025	295	0.0%	4,629	3/31/2025
2024 Q4	2/13/2025	229	0.0%	4,781	12/31/2024
2024 Q3	11/14/2024	293	0.0%	5,121	9/30/2024
2024 Q2	8/13/2024	268	0.0%	5,121	6/30/2024
2024 Q1	5/15/2024	233	0.0%	5,735	3/31/2024
2023 Q4	2/14/2024	212	0.0%	5,735	12/31/2023
2023 Q3	11/14/2023	241	0.0%	6,303	9/30/2023
2023 Q2	8/10/2023	227	0.0%	6,303	6/30/2023
2023 Q1	5/11/2023	262	0.0%	6,862	3/31/2023
2022 Q4	2/13/2023	390	0.0%	6,862	12/31/2022
2022 Q3	11/14/2022	288	0.0%	7,274	9/30/2022
2022 Q2	8/11/2022	320	0.0%	7,274	6/30/2022
2022 Q1	5/12/2022	290	0.0%	7,274	3/31/2022
2021 Q4	2/11/2022	292	0.0%	7,274	12/31/2021
2021 Q3	11/15/2021	296	0.0%	7,274	9/30/2021
2021 Q2	8/12/2021	330	0.0%	7,274	6/30/2021
2021 Q1	5/14/2021	303	0.0%	7,274	3/31/2021
2020 Q4	2/16/2021	311	0.0%	7,274	12/31/2020